Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 19:20
Anika Therapeutics Market Cap : 285.19M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 291.48M |
| August 20, 2026 | 285.59M |
| August 19, 2026 | 284.52M |
| August 18, 2026 | 288.67M |
| August 17, 2026 | 287.33M |
| August 14, 2026 | 287.73M |
| August 13, 2026 | 283.32M |
| August 12, 2026 | 294.83M |
| August 11, 2026 | 284.12M |
| August 10, 2026 | 276.76M |
| August 07, 2026 | 286.66M |
| August 06, 2026 | 269.80M |
| August 05, 2026 | 256.82M |
| August 04, 2026 | 262.44M |
| August 03, 2026 | 277.50M |
| July 31, 2026 | 258.02M |
| July 30, 2026 | 241.83M |
| July 29, 2026 | 216.40M |
| July 28, 2026 | 202.75M |
| July 27, 2026 | 201.01M |
| July 24, 2026 | 199.69M |
| July 23, 2026 | 195.95M |
| July 22, 2026 | 200.49M |
| July 21, 2026 | 202.49M |
| July 20, 2026 | 201.16M |
| Date | Value |
|---|---|
| July 17, 2026 | 203.69M |
| July 16, 2026 | 211.31M |
| July 15, 2026 | 212.78M |
| July 14, 2026 | 207.30M |
| July 13, 2026 | 210.64M |
| July 10, 2026 | 208.37M |
| July 09, 2026 | 214.91M |
| July 08, 2026 | 218.25M |
| July 07, 2026 | 211.98M |
| July 06, 2026 | 214.11M |
| July 02, 2026 | 205.16M |
| July 01, 2026 | 202.76M |
| June 30, 2026 | 195.41M |
| June 29, 2026 | 200.49M |
| June 26, 2026 | 201.69M |
| June 25, 2026 | 195.28M |
| June 24, 2026 | 196.75M |
| June 23, 2026 | 194.88M |
| June 22, 2026 | 189.67M |
| June 18, 2026 | 192.61M |
| June 17, 2026 | 190.07M |
| June 16, 2026 | 191.01M |
| June 15, 2026 | 195.15M |
| June 12, 2026 | 196.62M |
| June 11, 2026 | 196.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 362.79M |
| MiMedx Group, Inc. | 623.70M |
| ABVC BioPharma, Inc. | 21.76M |
| Enovis Corp. | 1.454B |
| Edwards Lifesciences Corp. | 52.19B |
Market Cap Related Metrics
| PS Ratio | 2.488 |
| Price to Book Value | 2.077 |
| Price to Free Cash Flow | 534.04 |
| Price | 21.31 |
| Earnings Yield | -1.29% |